BMO EqWt US HthCare Hedged CAD

ZUH-T

Analysis and Opinions about ZUH-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
January 30, 2020

60 names, equally weighted. Prefers names like JNJ, Bristol Myers, UNH, or Merck. His ETF strategy is VHT in US dollars, with more exposure to larger names. Healthcare will be choppy, but it's cheap. Demographics are in its favour.

Show full opinionHide full opinion

60 names, equally weighted. Prefers names like JNJ, Bristol Myers, UNH, or Merck. His ETF strategy is VHT in US dollars, with more exposure to larger names. Healthcare will be choppy, but it's cheap. Demographics are in its favour.

TOP PICK
TOP PICK
June 3, 2019
It has been beaten up a little because of Big Pharma overcharging and so for but the demographics don't change. It is time to go. A timely hold.
Show full opinionHide full opinion
It has been beaten up a little because of Big Pharma overcharging and so for but the demographics don't change. It is time to go. A timely hold.
COMMENT
COMMENT
April 24, 2019
A laggard. Only 10% is in the managed care. Like clock word every election period, these stocks go under a lot of pressure. He mentions an article from the WSJ thus weekend that suggest that the sector has gone through enough of a correction that now it shows good value. Doesn't have enough yield.
Show full opinionHide full opinion
A laggard. Only 10% is in the managed care. Like clock word every election period, these stocks go under a lot of pressure. He mentions an article from the WSJ thus weekend that suggest that the sector has gone through enough of a correction that now it shows good value. Doesn't have enough yield.
TOP PICK
TOP PICK
April 2, 2019
Baby boomers are going from the age of Aquarius to the age of arthritis. A demographic play. Expense ratio: 0.39%. Well diversified. 20% big Pharma. Hospitals and other related to health care. hedged to Canadian.
Show full opinionHide full opinion
Baby boomers are going from the age of Aquarius to the age of arthritis. A demographic play. Expense ratio: 0.39%. Well diversified. 20% big Pharma. Hospitals and other related to health care. hedged to Canadian.
BUY
BUY
March 28, 2019
In election years the rhetoric on the sector makes prices moves even 3-4% in a day. Having said all that he thinks it is a great place to be.
Show full opinionHide full opinion
In election years the rhetoric on the sector makes prices moves even 3-4% in a day. Having said all that he thinks it is a great place to be.
COMMENT
COMMENT
November 20, 2017

Likes the sector and this ETF. Its US based and well diversified. It’s not just big Pharma, but is various hospital services, management, etc. Given the demographics, the population, etc., it is a really good growth area.

Show full opinionHide full opinion

Likes the sector and this ETF. Its US based and well diversified. It’s not just big Pharma, but is various hospital services, management, etc. Given the demographics, the population, etc., it is a really good growth area.

John Hood

Unlock Ratings

Price
$48.470
Owned
Unknown
BUY
BUY
July 8, 2016

This dropped when the biotech industry was getting hammered on costs by US politicians. It had quite a good run, and probably got overbought and over owned. It has gone through quite a significant correction. Technically it looks like it has sort of bottomed. Probably not a bad time to enter.

Show full opinionHide full opinion

This dropped when the biotech industry was getting hammered on costs by US politicians. It had quite a good run, and probably got overbought and over owned. It has gone through quite a significant correction. Technically it looks like it has sort of bottomed. Probably not a bad time to enter.

BUY
BUY
June 2, 2016

Healthcare ETF. There is no Canadian one. He likes this one.

Show full opinionHide full opinion

Healthcare ETF. There is no Canadian one. He likes this one.

John Hood

Unlock Ratings

Price
$41.410
Owned
Unknown
PAST TOP PICK
PAST TOP PICK
February 16, 2016

(A Top Pick Feb 17/15. Down 9.16%.) This is down because there was not the pickup from the US$, as well as all the questions about mispricing among the big pharmas. Still likes this, because it is not that big on just pharma, but is also in hospital management and different kinds of services. Thinks there is going to be a pretty good market for health services over the next several years. If there is any weakness in it, buy it.

Show full opinionHide full opinion

(A Top Pick Feb 17/15. Down 9.16%.) This is down because there was not the pickup from the US$, as well as all the questions about mispricing among the big pharmas. Still likes this, because it is not that big on just pharma, but is also in hospital management and different kinds of services. Thinks there is going to be a pretty good market for health services over the next several years. If there is any weakness in it, buy it.

PAST TOP PICK
PAST TOP PICK
January 18, 2016

(A Top Pick Feb 17/15. Down 6.17%.) Healthcare has been beaten up, and he likes the sector. It is well diversified amongst the companies. It has service providers, labs, etc.

Show full opinionHide full opinion

(A Top Pick Feb 17/15. Down 6.17%.) Healthcare has been beaten up, and he likes the sector. It is well diversified amongst the companies. It has service providers, labs, etc.

BUY
BUY
October 21, 2015

1 or 2 ETF’s in healthcare? A lot of the big Pharmas are coming under pressure because there is a question of price gouging by a number of Pharmas, and that is being investigated in the US. He tends to look for the ETF’s that are not just big Pharmas, but more into biotech, healthcare, hospital management, insurance, etc. This is the one that he prefers and it is Cdn$ hedged.

Show full opinionHide full opinion

1 or 2 ETF’s in healthcare? A lot of the big Pharmas are coming under pressure because there is a question of price gouging by a number of Pharmas, and that is being investigated in the US. He tends to look for the ETF’s that are not just big Pharmas, but more into biotech, healthcare, hospital management, insurance, etc. This is the one that he prefers and it is Cdn$ hedged.

BUY
BUY
August 27, 2015

Loves healthcare ETF’s. Keep in mind that in this ETF there is the Pfizer’s and the Merc’s. It is important that everybody should have some healthcare in their portfolio. Equal weight will usually outperform market weight.

Show full opinionHide full opinion

Loves healthcare ETF’s. Keep in mind that in this ETF there is the Pfizer’s and the Merc’s. It is important that everybody should have some healthcare in their portfolio. Equal weight will usually outperform market weight.

BUY
BUY
August 27, 2015

A healthcare ETF? When it comes to healthcare ETF’s, a lot of them have a very large weighting in pharmaceuticals. A lot of the larger names have not done very well. The space you want to be in would be more of the biotech and healthcare benefit providers.

Show full opinionHide full opinion

A healthcare ETF? When it comes to healthcare ETF’s, a lot of them have a very large weighting in pharmaceuticals. A lot of the larger names have not done very well. The space you want to be in would be more of the biotech and healthcare benefit providers.

PAST TOP PICK
PAST TOP PICK
August 6, 2015

(Top Pick Sep 26/14, Up 26.76%) He would be reducing. Take the money and protect yourself. It is starting to top out.

Show full opinionHide full opinion

(Top Pick Sep 26/14, Up 26.76%) He would be reducing. Take the money and protect yourself. It is starting to top out.

COMMENT
COMMENT
July 6, 2015

A basket of US healthcare stocks, Cdn$ denominated, so you don’t have to worry about currencies. He thinks this is a good deal. There is no sign of a downtrend and thinks it goes higher.

Show full opinionHide full opinion

A basket of US healthcare stocks, Cdn$ denominated, so you don’t have to worry about currencies. He thinks this is a good deal. There is no sign of a downtrend and thinks it goes higher.

Showing 1 to 15 of 32 entries

BMO EqWt US HthCare Hedged CAD(ZUH-T) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 1

Stockchase rating for BMO EqWt US HthCare Hedged CAD is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

BMO EqWt US HthCare Hedged CAD(ZUH-T) Frequently Asked Questions

What is BMO EqWt US HthCare Hedged CAD stock symbol?

BMO EqWt US HthCare Hedged CAD is a Canadian stock, trading under the symbol ZUH-T on the Toronto Stock Exchange (ZUH-CT). It is usually referred to as TSX:ZUH or ZUH-T

Is BMO EqWt US HthCare Hedged CAD a buy or a sell?

In the last year, 1 stock analyst published opinions about ZUH-T. 0 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is DON'T BUY. Read the latest stock experts' ratings for BMO EqWt US HthCare Hedged CAD.

Is BMO EqWt US HthCare Hedged CAD a good investment or a top pick?

BMO EqWt US HthCare Hedged CAD was recommended as a Top Pick by Stan Wong on 2020-01-30. Read the latest stock experts ratings for BMO EqWt US HthCare Hedged CAD.

Why is BMO EqWt US HthCare Hedged CAD stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is BMO EqWt US HthCare Hedged CAD worth watching?

1 stock analyst on Stockchase covered BMO EqWt US HthCare Hedged CAD In the last year. It is a trending stock that is worth watching.

What is BMO EqWt US HthCare Hedged CAD stock price?

On 2020-04-03, BMO EqWt US HthCare Hedged CAD (ZUH-T) stock closed at a price of $50.15.